| NF1 | Neurofibromatosis Type 1 |
| cNFs | cutaneous neurofibromas |
| pNFs | plexiform neurofibromas |
| MPNSTs | malignant peripheral nerve sheath tumors |
| HGMD® | Human Gene Mutation Database |
| GAP | GTPase-activating protein |
| NLS | nuclear localization signal |
| CSRD | cysteine/serine-rich domain |
| TBD | tubulin-binding region |
| GRD | GAP-related domain |
| LRD | leucine-rich domain |
| PH | pleckstrin homology |
| CTD | C-terminal domain |
| SBR | syndecan-binding region |
| SynGAP | synaptic RasGAP |
| PAM | PI3K/AKT/mTOR |
| AC | adenylyl cyclase |
| GPCR | G protein-coupled receptors |
| 5-HT6r | 5-hydroxytryptamine receptor 6 |
| LRPPRC | leucine-rich pentatricopeptide-repeat-containing protein |
| APP | amyloid precursor protein |
| CALMs | café-au-lait macules |
| LOH | loss of heterozygosity |
| PRC2 | Polycomb Repressive Complex 2 |
| AAV | adeno-associated virus |
| HSV | herpes simplex virus |
| CAR-T | chimeric antigen receptor T cell |
| oHSV | oncolytic herpes simplex virus |
| T-VEC | Talimogene laherparepvec |
| DLT | dose-limiting toxicities |
| MTD | maximum tolerated dose |
| CART | Antigen-specific cytokine-activated T cells |
| CTLs | cytotoxic T lymphocytes |
| DCvac | dendritic cell vaccine |
| LGG | low-grade glioma |
| rAAVs | recombinant adeno-associated viruses |
| hSCs | human Schwann cells |
| C10 | C-terminal 10 AA of HRAS domain |
| C24 | C-terminal 24 AA of KRAS4B |
| IF | Immunofluorescence |
| hNu | human nuclear antigen |
| RTKs | receptor tyrosine kinases |
| HDACis | histone deacetylase inhibitors |